Alzheimer’s Association International Conference 2024 (AAIC 2024)

Sildenafil, a phosphodiesterase type 5 inhibitor, can be a potential treatment for Alzheimer’s disease (AD), as shown in real-world data, AD patient-induced pluripotent stem cells (iPSC)-derived neuron models, and in vivo transgenic mouse model observations, according to a study presented at AAIC 2024.

In a study that tracked over 100,000 individuals for over 40 years, the risk of dementia is higher among those who consumed about two servings of processed red meat per week as opposed to those who consumed less.

A blood test for identifying Alzheimer’s disease (AD) among individuals with cognitive symptoms appears to be highly accurate, outperforming traditional methods used in the primary and secondary care settings, according to a study.